1. Home
  2. ACIU vs LMNR Comparison

ACIU vs LMNR Comparison

Compare ACIU & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AC Immune SA

ACIU

AC Immune SA

N/A

Current Price

$2.33

Market Cap

229.7M

Sector

Health Care

ML Signal

N/A

Logo Limoneira Co

LMNR

Limoneira Co

N/A

Current Price

$10.66

Market Cap

218.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
ACIU
LMNR
Founded
2003
1893
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
229.7M
218.5M
IPO Year
2015
2005

Fundamental Metrics

Financial Performance
Metric
ACIU
LMNR
Price
$2.33
$10.66
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$8.60
★ $20.83
AVG Volume (30 Days)
★ 193.5K
128.2K
Earning Date
11-04-2026
12-22-2026
Dividend Yield
N/A
★ 0.70%
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $159,723,000.00
Revenue This Year
$422.39
N/A
Revenue Next Year
$377.85
$17.92
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.02
$10.05
52 Week High
$3.90
$15.43

Technical Indicators

Market Signals
Indicator
ACIU
LMNR
Relative Strength Index (RSI) 48.00 43.13
Support Level $2.09 N/A
Resistance Level $2.47 $13.71
Average True Range (ATR) 0.16 0.47
MACD 0.00 0.04
Stochastic Oscillator 60.40 48.11

Price Performance

Historical Comparison
ACIU
LMNR

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

Share on Social Networks: